SinoPep timeline
Every SinoPep batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| SNP-2607-C3886 | CJC-1295 with DAC | 11 Jul 2026 | 2026-Q3 | 2 | 99.17 | 0.15 | 99.16 | -0.01 | |
| SNP-2606-D4620 | IGF-1 LR3 | 25 Jun 2026 | 2026-Q3 | 11 | 98.49 | 0.81 | 99.04 | +0.55 | |
| SNP-2606-L4478 | Ipamorelin | 01 Jun 2026 | 2026-Q3 | 7 | 99.13 | 0.71 | 99.16 | +0.03 | |
| SNP-2605-G4075 | ARA-290 | 27 May 2026 | 2026-Q2 | 2 | 99.07 | 0.26 | 99.12 | +0.05 | |
| SNP-2603-C5177 | Cagrilintide | 09 Mar 2026 | 2026-Q2 | 1 | 98.41 | n<2 | 98.97 | +0.56 | |
| SNP-2603-G4042 | Retatrutide | 02 Mar 2026 | 2026-Q1 | 12 | 97.58 | 0.67 | 97.22 | -0.36 | SHARED BULK |
| SNP-2602-U4281 | Mazdutide | 24 Feb 2026 | 2026-Q2 | 8 | 97.91 | 0.72 | 99.90 | +1.99 | |
| SNP-2602-B3833 | Ipamorelin | 04 Feb 2026 | 2026-Q3 | 9 | 99.93 | 0.20 | 99.90 | -0.03 | SHARED BULK |
| SNP-2601-N5064 | Ipamorelin | 20 Jan 2026 | 2026-Q1 | 1 | 98.83 | n<2 | 98.88 | +0.05 | |
| SNP-2601-U4736 | Semax | 12 Jan 2026 | 2026-Q1 | 10 | 99.52 | 1.00 | 99.36 | -0.16 | SHARED BULK |
| SNP-2511-P4283 | Semaglutide | 04 Nov 2025 | 2026-Q2 | 10 | 98.15 | 1.29 | 97.65 | -0.50 | |
| SNP-2509-A4337 | Semaglutide | 21 Sep 2025 | 2026-Q1 | 6 | 98.57 | 0.25 | 98.89 | +0.32 | |
| SNP-2507-J5248 | Semax | 11 Jul 2025 | 2025-Q4 | 5 | 99.46 | 1.08 | 99.09 | -0.37 | |
| SNP-2506-U4547 | BPC-157 | 06 Jun 2025 | 2025-Q3 | 9 | 98.98 | 1.11 | 99.00 | +0.02 | |
| SNP-2505-V3856 | TB-500 | 23 May 2025 | 2025-Q2 | 2 | 99.23 | 0.48 | 98.40 | -0.83 | |
| SNP-2505-A3973 | Tirzepatide | 05 May 2025 | 2025-Q2 | 5 | 98.72 | 0.50 | 98.88 | +0.16 | |
| SNP-2503-J5227 | Enclomiphene citrate | 11 Mar 2025 | 2025-Q3 | 4 | 98.82 | 0.89 | 98.89 | +0.07 | |
| SNP-2502-G4494 | Semaglutide | 28 Feb 2025 | 2025-Q3 | 1 | 98.29 | n<2 | 98.79 | +0.50 | |
| SNP-2502-N4153 | BPC-157 | 21 Feb 2025 | 2025-Q3 | 6 | 99.77 | 0.37 | 99.28 | -0.49 | |
| SNP-2502-X4903 | Tirzepatide | 12 Feb 2025 | 2025-Q2 | 10 | 98.63 | 0.62 | 99.13 | +0.50 | |
| SNP-2501-E3910 | BPC-157 | 11 Jan 2025 | 2025-Q2 | 5 | 99.57 | 0.60 | 99.43 | -0.14 | |
| SNP-2412-F3914 | Enclomiphene citrate | 20 Dec 2024 | 2025-Q1 | 6 | 99.58 | 0.73 | 99.50 | -0.08 | |
| SNP-2412-E4702 | CJC-1295 with DAC | 13 Dec 2024 | 2025-Q1 | 4 | 98.49 | 0.59 | 98.28 | -0.21 | |
| SNP-2411-S4752 | PEG-MGF | 23 Nov 2024 | 2025-Q1 | 1 | 97.17 | n<2 | 96.98 | -0.19 | |
| SNP-2411-Y4474 | Tirzepatide | 15 Nov 2024 | 2025-Q2 | 2 | 98.29 | 0.00 | 98.05 | -0.24 | |
| SNP-2411-T4814 | IGF-1 LR3 | 15 Nov 2024 | 2025-Q1 | 1 | 98.48 | n<2 | 97.73 | -0.75 | |
| SNP-2411-X3762 | LL-37 | 07 Nov 2024 | 2025-Q1 | 9 | 99.30 | 0.98 | 99.50 | +0.20 | |
| SNP-2408-A4044 | Mazdutide | 16 Aug 2024 | 2024-Q3 | 4 | 98.72 | 1.70 | 98.68 | -0.04 | |
| SNP-2408-Y4383 | BPC-157 | 07 Aug 2024 | 2025-Q1 | 4 | 99.04 | 0.33 | 99.45 | +0.41 | |
| SNP-2405-T4694 | Retatrutide | 15 May 2024 | 2024-Q4 | 5 | 98.15 | 0.99 | 97.48 | -0.67 |